Description
VFEND® (voriconazole), a triazole antifungal agent that helps fight life threatening fungal infections.
- Vfend
- Pfizer Ophthalmics
- Inquire
- I.V. for Injection: 200 mg Vials
Tablets: 50 mg, 200 mg
Oral Suspension: 100 mL - VFEND is indicated for use in the treatment of the following fungal infections:
Invasive aspergillosis. In clinical trials, the majority of isolates recovered were Aspergillus fumigatus.
Candidemia in nonneutropenic patients and the following Candida infections: disseminated infections in skin and infections in abdomen, kidney, bladder wall, and wounds
Esophageal candidiasis (see CLINICAL STUDIES, MICROBIOLOGY).
Serious fungal infections caused by Scedosporium apiospermum (asexual form of Pseudallescheria
boydii) and Fusarium spp. including Fusarium solani, in patients intolerant of, or refractory to, other
therapy - VFEND I.V. for Injection unreconstituted vials should be stored at 15° - 30° C (59° - 86° F)
VFEND Tablets should be stored at 15° - 30° C (59° - 86° F) [see USP Controlled Room
Temperature].
VFEND Powder for Oral Suspension should be stored at 2° - 8° C (36°- 46° F) (in a refrigerator)
before reconstitution. The shelf-life of the powder for oral suspension is 18 months.
The reconstituted suspension should be stored at 15° - 30° C (59° - 86° F) [see USP Controlled Room
Temperature]. Do not refrigerate or freeze. Keep the container tightly closed. The shelf-life of the
reconstituted suspension is 14 days. Any remaining suspension should be discarded 14 days after
reconstitution. - I.V. for Injection / Tablets / Oral Suspension
- Voriconazole